Early combined treatment with carboplatin and the MMP inhibitor, prinomastat, prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples